Cancer Vaccines Market Size, Share, Industry, Forecast and outlook (2024-2031)

Cancer vaccines market size was valued USD million in 2023 and is estimated to reach USD million by 2031, growing at a CAGR of 18% during the forecast period (2024-2031). Cancer is a malignant tumor caused by uncontrollable cell development in the body.

It can be treated with a variety of drugs and vaccinations. Vaccines are widely classified as either preventative or therapeutic. Preventive cancer vaccinations are used to prevent oncovirus-caused cancer and to protect against human papillomavirus (HPV), whereas therapeutic vaccines stimulate the individual adaptive immune systems by employing tumor antigens. Cancer vaccines are available in various forms, including antigen, dendritic cell, and anti-idiotype. There are several vaccines such as personalized cancer vaccines, anthrax vaccines, and other types of vaccines.